SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John S. Baker who wrote (1003)8/1/1998 11:38:00 AM
From: jake burns  Read Replies (2) of 1510
 
Lest I am mistaken, I believe most stocks would take off upon the filing of the application to the fda, not on approval. I would expect IMNR to be no different. And, a lot of time, the approval does nothing for the stock price because it was built into the price already since it was assumed it would be granted. How do people here feel about IMNR/Remune? I suppose whether the approval is built in will be apparent by the stock's price around the time the fda grants its decision.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News